Dr. Rolla Abu-Arja, M.D

NPI: 1750590790
Total Payments
$13,472
2024 Payments
$13,263
Companies
6
Transactions
13

Payment Breakdown by Category

Consulting$11,634 (86.4%)
Travel$1,270 (9.4%)
Food & Beverage$568.92 (4.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $11,634 1 86.4%
Travel and Lodging $1,270 4 9.4%
Food and Beverage $568.92 8 4.2%

Top Paying Companies

Company Total Records Latest Year
GENZYME CORPORATION $13,177 7 $0 (2024)
Novartis Pharmaceuticals Corporation $96.08 1 $0 (2022)
VERTEX PHARMACEUTICALS INCORPORATED $86.06 1 $0 (2024)
Adaptive Biotechnologies Corporation $53.82 2 $0 (2023)
Jazz Pharmaceuticals Inc. $39.56 1 $0 (2017)
bluebird bio, Inc. $19.72 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $13,263 8 GENZYME CORPORATION ($13,177)
2023 $73.54 3 Adaptive Biotechnologies Corporation ($53.82)
2022 $96.08 1 Novartis Pharmaceuticals Corporation ($96.08)
2017 $39.56 1 Jazz Pharmaceuticals Inc. ($39.56)

All Payment Transactions

13 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
11/14/2024 GENZYME CORPORATION Consulting Fee Cash or cash equivalent $11,634.00 General
11/14/2024 GENZYME CORPORATION Travel and Lodging In-kind items and services $714.01 General
11/14/2024 GENZYME CORPORATION Travel and Lodging In-kind items and services $301.39 General
11/14/2024 GENZYME CORPORATION Food and Beverage In-kind items and services $259.83 General
11/14/2024 GENZYME CORPORATION Travel and Lodging In-kind items and services $236.16 General
11/14/2024 GENZYME CORPORATION Travel and Lodging Cash or cash equivalent $18.00 General
11/14/2024 GENZYME CORPORATION Food and Beverage Cash or cash equivalent $13.85 General
02/21/2024 VERTEX PHARMACEUTICALS INCORPORATED CASGEVY (Biological) Food and Beverage In-kind items and services $86.06 General
Category: SICKLE CELL DISEASE/BETA THALESSEMIA
11/08/2023 bluebird bio, Inc. Food and Beverage In-kind items and services $19.72 General
07/06/2023 Adaptive Biotechnologies Corporation clonoSEQ (Device) Food and Beverage Cash or cash equivalent $35.75 General
Category: ONCOLOGY
06/14/2023 Adaptive Biotechnologies Corporation clonoSEQ (Device) Food and Beverage Cash or cash equivalent $18.07 General
Category: ONCOLOGY
07/27/2022 Novartis Pharmaceuticals Corporation KYMRIAH (Biological) Food and Beverage In-kind items and services $96.08 General
Category: ONCOLOGY
02/24/2017 Jazz Pharmaceuticals Inc. Defitelio (Drug) Food and Beverage In-kind items and services $39.56 General
Category: Hematology

About Dr. Rolla Abu-Arja, M.D

Dr. Rolla Abu-Arja, M.D is a Pediatric Emergency Medicine healthcare provider based in Columbus, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2007. The National Provider Identifier (NPI) number assigned to this provider is 1750590790.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rolla Abu-Arja, M.D has received a total of $13,472 in payments from pharmaceutical and medical device companies, with $13,263 received in 2024. These payments were reported across 13 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($11,634).

Practice Information

  • Specialty Pediatric Emergency Medicine
  • Other Specialties Pediatric Hematology-Oncology, Pediatrics
  • Location Columbus, OH
  • Active Since 05/22/2007
  • Last Updated 09/10/2025
  • Taxonomy Code 2080P0204X
  • Entity Type Individual
  • NPI Number 1750590790

Products in Payments

  • KYMRIAH (Biological) $96.08
  • CASGEVY (Biological) $86.06
  • clonoSEQ (Device) $53.82
  • Defitelio (Drug) $39.56

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatric Emergency Medicine Doctors in Columbus